Corteva, Inc. 2024 Q2 10-Q Filing Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024, for Corteva, Inc. (CTVA), a global leader in agricultural science. The filing is a combined report for Corteva and its subsidiary, EIDP, Inc. Corteva operates through two reportable segments: Seed and Crop Protection. The company is a large accelerated filer and is not a shell company.
Key Financial Metrics
| Metric (in millions) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $6,112 | $6,045 | $10,604 | $10,929 |
| Net Income (Attributable to Corteva) | $1,053 | $714 | $1,472 | $1,309 |
| Diluted EPS | $1.51 | $1.00 | $2.10 | $1.83 |
| Operating EBITDA (Non-GAAP) | $1,917 | $1,746 | $2,951 | $2,977 |
| Cash & Equivalents | $1,839 | $2,563 | $1,839 | $2,563 |
| Total Debt | $4,724 | $5,313 | $4,724 | $5,313 |
| Operating Cash Flow (Continuing Ops) | — | — | $(1,999) | $(2,480) |
Note: Operating cash flow for the six months ended June 30, 2024, was negative due to seasonal working capital requirements, primarily driven by receivables and deferred revenue timing.
Material Changes vs. Prior Period
- Revenue: Q2 2024 net sales increased 1% year-over-year, driven by a 2% price increase partially offset by a 1% unfavorable portfolio impact. YTD sales decreased 3% due to a 4% volume decline and 1% currency headwind, partially offset by a 2% price increase.
- Profitability: Net income attributable to Corteva rose 47% in Q2 ($1.053B vs. $714M) and 12% YTD ($1.472B vs. $1.309B). This improvement was driven by Seed price execution, reduced royalty expenses, and cost productivity actions.
- Segment Performance:
- Seed: Q2 sales up 2%; Operating EBITDA up 16% to $1.698B. Margins improved by ~500 basis points.
- Crop Protection: Q2 sales flat; Operating EBITDA down 20% to $255M due to competitive pricing pressures and raw material inflation.
- Restructuring: Restructuring and asset-related charges increased to $92M in Q2 (vs. $60M in Q2 2023) and $167M YTD (vs. $93M YTD 2023). These charges relate to the Crop Protection Operations Strategy Restructuring Program and accelerated royalty amortization.
- Debt: Total debt increased to $4.724B from $2.489B at year-end 2023, primarily due to higher short-term borrowings used to fund seasonal working capital needs.
Guidance, Outlook, and Risks
- Full-Year 2024 Outlook:
- Net Sales: $17.2B – $17.5B
- Operating EBITDA: $3.4B – $3.6B
- Operating EPS: $2.60 – $2.80
- Free Cash Flow: $1.5B – $2.0B
- Capital Allocation: The company returned approximately $730M to shareholders in the first half of 2024 via dividends and share repurchases. The Board approved a 6.25% dividend increase to $0.17 per share. The company expects to repurchase approximately $1B of stock in 2024.
- Restructuring Outlook: The company expects to record an additional $180M–$230M in net pre-tax restructuring charges for the remainder of 2024 related to the Crop Protection optimization program.
- Risks and Contingencies:
- Legal Proceedings: Significant exposure remains regarding legacy PFAS litigation (subject to cost-sharing MOU with Chemours/DuPont), FTC antitrust investigations, and Lorsban® personal injury lawsuits.
- Market Conditions: Pricing pressures in Crop Protection, competitive environments, and unfavorable weather impacts on volumes.
- Currency: Continued volatility in foreign exchange rates, particularly the Turkish Lira, Brazilian Real, and Euro.
Investor Verification Checklist
- Working Capital Seasonality: Verify the timing of cash flow recovery in H2 2024 given the negative operating cash flow in H1 driven by receivables and deferred revenue.
- Restructuring Execution: Monitor the completion of the Crop Protection Operations Strategy Restructuring Program and the realization of the estimated $100M run-rate savings by 2025.
- Legal Exposure: Track developments in the FTC lawsuit, Lorsban® litigation, and the status of the Nationwide Water District Settlement fund.
- Crop Protection Margins: Assess whether competitive pricing pressures and input cost inflation will persist or subside in the second half of 2024 as management anticipates.
- Argentina Exposure: Review the impact of the Argentine Peso devaluation and the company's strategy regarding USD-denominated bonds to manage net monetary asset exposure.